THE WNT SIGNALING CASCADE AS A POTENTIAL NOVEL BIOMARKER OF TRIPLE NEGATIVE BREAST CANCER (TNBC)

被引：0
|
作者：
Huelsewig, C. [1 ]
Ruckert, C. [1 ]
Goette, M. [1 ]
von Wahlde, M. K. [1 ]
Buchweitz, O. [2 ]
Kiesel, L. [1 ]
Pusztai, L. [3 ]
Liedtke, C. [1 ]
机构：
[1] Univ Munster, Munster, Germany
[2] Tagesklin Altonaer Str, Hamburg, Germany
[3] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] Physical activity and breast cancer: Role of inhibition of Wnt signaling in triple negative breast cancer
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (01): : 582 - 582
  • [22] Preferential Inhibition of Wnt/-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
    Gangrade, Abhishek
    Pathak, Vibha
    Augelli-Szafran, Corinne E.
    Wei, Han-Xun
    Oliver, Patsy
    Suto, Mark
    Buchsbaum, Donald J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [23] OTULIN couples WNT signaling to resistance in triple-negative breast cancer
    Wang, Wei
    Wu, Zhao-Hui
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (06)
  • [24] Triple-negative breast cancer: understanding Wnt signaling in drug resistance
    Parnaz Merikhian
    Mohammad Reza Eisavand
    Leila Farahmand
    Cancer Cell International, 21
  • [25] Triple-negative breast cancer: understanding Wnt signaling in drug resistance
    Merikhian, Parnaz
    Eisavand, Mohammad Reza
    Farahmand, Leila
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [26] Copper chaperons as novel targets for therapy in triple-negative breast cancer (TNBC)
    Karginova, O.
    Song, A.
    Wang, J.
    Luo, C.
    Jiang, H.
    He, C.
    Olopade, O. I.
    CANCER RESEARCH, 2016, 76
  • [27] SRC as a novel therapeutic target fot the treatment of triple negative breast cancer (TNBC)
    Walsh, S.
    Tryfonopoulos, D.
    Quinn, C.
    Flanagan, L.
    Pierce, A.
    McDermott, E. W.
    Evoy, D.
    O'Donovan, N.
    Crown, J.
    Duffy, M. J.
    BRITISH JOURNAL OF SURGERY, 2011, 98 : 25 - 26
  • [28] Biomarker identification of residual triple negative breast cancer (TNBC) after standard neoadjuvant chemotherapy (NCT)
    Sohn, Joohyuk
    Liu, Shuyling
    Chen, Huiqin
    Meng, Xiaolong
    Kim-Anh Do
    Mills, Gordon B.
    Hortobagyi, Gabriel N.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    CANCER RESEARCH, 2012, 72
  • [29] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [30] Current usage of pembrolizumab in triple negative breast cancer (TNBC)
    O'Rourke, Harriet
    Hart, Christopher
    De Boer, Richard H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (05) : 253 - 261
12345